Add Company
Join Now

Purisys Revenue and Competitors

License our Company Data API

Athens, GA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Purisys's estimated annual revenue is currently $5M per year.(i)
  • Purisys's estimated revenue per employee is $201,000

Employee Data

  • Purisys has 25 Employees.(i)
  • Purisys grew their employee count by 4% last year.

Purisys's People

NameTitleEmail/Phone
1
General Manager Purisys, LLC and VP, R&D Noramco LLCReveal Email/Phone
2
Director, Product Development and Regulatory CMCReveal Email/Phone
3
Director, SalesReveal Email/Phone
4
Senior Manager, Operations and Supply ChainReveal Email/Phone
5
Principal ScientistReveal Email/Phone
6
Senior Logistics SpecialistReveal Email/Phone
7
Process ScientistReveal Email/Phone
8
Quality Control LeadReveal Email/Phone
9
QC Laboratory AnalystReveal Email/Phone
10
Research And Development TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.5M1228%N/AN/A
#2
$10.7M53-17%N/AN/A
#3
$9.2M462%N/AN/A
#4
$24.1M1205%N/AN/A
#5
$7.2M36-20%N/AN/A
#6
$27.7M138-30%N/AN/A
#7
$39.8M19837%N/AN/A
#8
$0.5M525%$50MN/A
#9
$13.7M68-7%N/AN/A
#10
$10.3M5111%N/AN/A
Add Company

What Is Purisys?

Purisys is a global leader in custom synthesis of active pharmaceutical ingredients and advanced intermediates. We support pharma & biotech companies with APIs, reference standards, controlled substances, cannabinoids and cGMP clinical & niche commercial CDMO services. Formed as a spin-off from Noramco in 2019, Purisys began manufacturing in 1979 as part of Johnson & Johnson. WORLD LEADER IN PHARMACEUTICAL CANNABINOIDS & CANNABINOID REFERENCE STANDARDS Purisys produces 50+ major and minor cannabinoids, as well as degradants, metabolites & analytical standards to support our customers in this growing field. We have Drug Master Files for multiple compounds, including Dronabinol (DMF#20682), CBD (DMF# 33223), Nabilone (DMF# 35408), and have produced other cannabinoids used worldwide in IND/IMPD/NDA/ANDA filings. CUSTOM API and DRUG DEVELOPMENT & MANUFACTURING (CDMO) SERVICES FOR PHARMA & BIOTECH For clients seeking preclinical-to-commercial APIs, we provide comprehensive development, analytical and manufacturing services - including full-service clinical-to-commercial small volume & orphan drug commercial API synthesis in our FDA-inspected GMP manufacturing suites. Our custom synthesis projects include difficult-to-manufacture APIs (controlled substances, injectable-grade APIs, HPAPIs and environmentally sensitive APIs). IN-STOCK REFERENCE STANDARDS AND CUSTOM SYNTHESIS SERVICES Purisys stocks 250+ reference standards with structural elucidation and comprehensive analytical data. We ship reference standards to 30+ countries on 6 continents. We can perform rapid standards development & qualification – including custom synthesis of degradation products, metabolites and other impurities. CAPABILITIES: • Pharma grade cannabinoid APIs & reference standards • In-stock standards; custom synthesis & qualification • Excipient compatibility & formulation & solid state • cGMP manufacturing • Custom API, high potency API & labile molecule development • Method development

keywords:N/A

N/A

Total Funding

25

Number of Employees

$5M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.7M250%N/A
#2
$5.7M25-7%N/A
#3
$2.5M2514%N/A
#4
$2.5M250%N/A
#5
$3.1M250%N/A